Weiss Multi-Strategy Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$278K	–	854
2021 Q3	$278K	Buy	+2,000	New	+$250K	0.01%	612
2021 Q1	–	Sell	-29,200	Closed	-$2.5M	–	934
2020 Q4	$2.5M	Buy	+29,200	New	+$2.47M	0.05%	377
2020 Q2	–	Sell	-44,900	Closed	-$1.53M	–	651
2020 Q1	$1.53M	Buy	+44,900	New	+$2.05M	0.06%	269
2019 Q4	–	Sell	-5,000	Closed	-$209K	–	801
2019 Q3	$209K	Buy	+5,000	New	+$211K	﹤0.01%	544

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BHVN Position: Q3 2022 in Review

Weiss Multi-Strategy Advisers sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 60,000 shares — an estimated $8.74M sold.

Weiss Multi-Strategy Advisers first reported a position in BHVN in Q2 2018 and held it in 17 quarters. The position peaked at $10.4M in Q3 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Weiss Multi-Strategy Advisers reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 60,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $8.74M.
Weiss Multi-Strategy Advisers first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 17 quarters.
Weiss Multi-Strategy Advisers's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.4M in Q3 2021.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.